AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $11.75M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| IMC | Immuron CEO to Present at RedChip Global Online Growth Conf | 24/04/18 | ||
| IMC | Travelan Sales Continue to Soar in Third Quarter of FY2018 | PRICE SENSITIVE | 23/04/18 | |
| IMC | Becoming a substantial holder | 20/03/18 | ||
| IMC | ASX Documentation Request - Reduction of Capital (Nov 2017) | 19/03/18 | ||
| IMC | Form 604 - Change in Substantial Shareholding (Grandlodge) | 19/03/18 | ||
| IMC | Appendix 3B & 708A Notice (Placement to US Fund Allotment) | 16/03/18 | ||
| IMC | Immuron Announces A$5.1M Private Placement to U.S. Fund | PRICE SENSITIVE | 14/03/18 | |
| IMC | Immuron Progresses Discussions with Institutional Funds | PRICE SENSITIVE | 13/03/18 | |
| IMC | Immuron Commences US Non-Deal Institutional Investor Roadshw | 13/03/18 | ||
| IMC | Trading Halt Request | 12/03/18 | ||
| IMC | Trading Halt | PRICE SENSITIVE | 12/03/18 | |
| IMC | Immuron Reports Positive Results in NASH Clinical Trial | PRICE SENSITIVE | 08/03/18 | |
| IMC | Correction to False and Misleading News Release | PRICE SENSITIVE | 07/03/18 | |
| IMC | Trading Halt | PRICE SENSITIVE | 07/03/18 | |
| IMC | Appendix 4D - Half Year Financial Report - 31 Dec 2017 | PRICE SENSITIVE | 28/02/18 | |
| IMC Immuron CEO to Present at RedChip Global Online Growth Conf | |||
| 24/04/18 | |||
| IMC Travelan Sales Continue to Soar in Third Quarter of FY2018 | |||
| 23/04/18 | PRICE SENSITIVE | ||
| IMC Becoming a substantial holder | |||
| 20/03/18 | |||
| IMC ASX Documentation Request - Reduction of Capital (Nov 2017) | |||
| 19/03/18 | |||
| IMC Form 604 - Change in Substantial Shareholding (Grandlodge) | |||
| 19/03/18 | |||
| IMC Appendix 3B & 708A Notice (Placement to US Fund Allotment) | |||
| 16/03/18 | |||
| IMC Immuron Announces A$5.1M Private Placement to U.S. Fund | |||
| 14/03/18 | PRICE SENSITIVE | ||
| IMC Immuron Progresses Discussions with Institutional Funds | |||
| 13/03/18 | PRICE SENSITIVE | ||
| IMC Immuron Commences US Non-Deal Institutional Investor Roadshw | |||
| 13/03/18 | |||
| IMC Trading Halt Request | |||
| 12/03/18 | |||
| IMC Trading Halt | |||
| 12/03/18 | PRICE SENSITIVE | ||
| IMC Immuron Reports Positive Results in NASH Clinical Trial | |||
| 08/03/18 | PRICE SENSITIVE | ||
| IMC Correction to False and Misleading News Release | |||
| 07/03/18 | PRICE SENSITIVE | ||
| IMC Trading Halt | |||
| 07/03/18 | PRICE SENSITIVE | ||
| IMC Appendix 4D - Half Year Financial Report - 31 Dec 2017 | |||
| 28/02/18 | PRICE SENSITIVE | ||
